Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Compass Therapeutics stock have an average target of 13.38, with a low estimate of 5.00 and a high estimate of 32. The average target predicts an increase of 658.07% from the current stock price of 1.77.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$13.38	$12	$32
Change	+183.29%	+658.07%	+579.89%	+1713.0%

Analyst Ratings

The average analyst rating for Compass Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	3	3	5	5	5
Buy	1	1	1	2	2	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	4	7	7	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $10 → $24	Strong Buy	Maintains	$10 → $24	+1,259.77%	Apr 4, 2025
Michael Schmidt Guggenheim	Guggenheim	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+579.89%	Apr 2, 2025
Andrew Berens Leerink Partners	Leerink Partners	Hold → Buy Upgrades $4 → $6	Hold → Buy	Upgrades	$4 → $6	+239.94%	Apr 2, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $32	Strong Buy	Maintains	$32	+1,713.03%	Apr 1, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $32	Strong Buy	Maintains	$32	+1,713.03%	Feb 27, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.26M

Increased by 47.65%

from 850.00K

Revenue Next Year

35.99M

Increased by 2,767.57%

from 1.26M

EPS This Year

-0.46

from -0.36

EPS Next Year

-0.48

from -0.46

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	850.00K	1.26M	35.99M	138.97M
Revenue Growth	-	-	-	-	-	47.65%	2,767.57%	286.16%
EPS	-0.96	-1.31	-0.37	-0.33	-0.36	-0.46	-0.48	-0.11
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	12	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	12.9M	81.7M	240.3M
Avg	1.3M	36.0M	139.0M
Low	n/a	6.3M	45.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	1,419.4%	6,406.7%	567.6%
Avg	47.6%	2,767.6%	286.2%
Low	-	405.4%	27.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.20	0.16	0.76
Avg	-0.46	-0.48	-0.11
Low	-0.59	-0.80	-0.68

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.